Zimmer & ISTO Technologies Announce Phase III Clinical Study

Zimmer and ISTO Technologies have announced a Phase III clinical study to evaluate DeNovo ET Engineered Tissue Graft, an engineered cartilage implant for repairing cartilage defects in the knee, according to a company news release.

Advertisement

The randomized, controlled study will generate meaningful use data. It will include 225 patients at up to 25 centers across the country. In the preclinical studies, cells derived from juvenile tissue showed significantly greater capacity for regenerating cartilage when compared with cells derived from adult cartilage.

Related Articles on Orthopedic Devices:

DJO Global Introduces Movation Total Knee Arthroplasty System

Zimmer Introduces Universal Power System & Surgical Saw Blades

Hanger Orthopedic Group Reports 9.5% 4Q Revenue Increase to $248M

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

  • From new technology acquisitions to regulatory clearances to leadership changes, here are 20 developments and updates from the biggest players…

  • SurGenTec’s ION-C earned FDA 510(k) clearance for ION-C navigation instruments with the ION-C posterior cervical facet fixation implant, according to…

  • VB Spine has made big pushes into the spine medtech space so far in 2026, including global expansions. Six headlines…

Advertisement

Comments are closed.